- Home
- ONC
as 09-15-2025 9:43am EST
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.
| Founded: | 2010 | Country: | Switzerland |
| Employees: | N/A | City: | BASEL |
| Market Cap: | 37.3B | IPO Year: | N/A |
| Target Price: | $335.78 | AVG Volume (30 days): | 365.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.66 | EPS Growth: | N/A |
| 52 Week Low/High: | $170.99 - $351.27 | Next Earning Date: | 11-11-2025 |
| Revenue: | $4,562,002,000 | Revenue Growth: | 47.33% |
| Revenue Growth (this year): | 875.58% | Revenue Growth (next year): | 20.99% |
Latest BeiGene Ltd. American Depositary Shares News
ONC Breaking Stock News: Dive into ONC Ticker-Specific Updates for Smart Investing
Insider Monkey
a day ago
Citizens JMP Maintains a Buy Rating on BeOne Medicines (ONC)
Investor's Business Daily
3 days ago
Hims & Hers Leads 15 Growth Stocks Amid Medical Boom
Insider Monkey
3 days ago
BeOne Medicines (ONC) Reports Positive Phase 1/2 Results for Sonrotoclax in MCL
Investor's Business Daily
5 days ago
China-Tied Biotechs Zai Labs, BeOne Plunge On Rumored Executive Order
MT Newswires
17 days ago
Sector Update: Health Care Stocks Decline Premarket Friday
MT Newswires
17 days ago
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday Ahead of Inflation Data
Business Wire
17 days ago
BeOne Medicines Announces Positive Topline Results for Sonrotoclax in Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Simply Wall St.
18 days ago
With 42% institutional ownership, BeOne Medicines Ltd. (NASDAQ:ONC) is a favorite amongst the big guns
Compare ONC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ONC BeiGene Ltd. American Depositary Shares - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.